About – NovaTerra Capital

About NovaTerra Capital

A Private Investment Fund Built for the Future of Cannabis

NovaTerra Capital is a private investment firm dedicated to funding, supporting, and scaling high-potential cannabis businesses in regulated, limited-license markets. By providing equity investments and active operational support, we position our portfolio companies for long-term success while delivering strong, risk-adjusted returns to our investors.

Our Mission

We connect institutional capital with high-potential operators, ensuring that promising cannabis businesses have the financial resources, operational expertise, and strategic guidance needed to thrive. Our approach is rooted in diversification, compliance, and scalable growth, helping investors gain exposure to one of the fastest-growing industries while mitigating risk.

What Makes NovaTerra Different?

NovaTerra Capital stands apart from traditional cannabis investment firms by combining institutional-grade investment discipline with active management and operational oversight. Our exclusive partnership with Tivity Labs enables us to go beyond passive investing by embedding industry-leading financial, regulatory, and strategic expertise into each portfolio company.

Our Investment Focus

We specialize in growth-stage cannabis operators in New Jersey and Maryland, two of the most promising, high-barrier-to-entry cannabis markets in the U.S. Our portfolio includes retail dispensaries, processors, manufacturers, and ancillary service providers, ensuring a well-balanced investment approach that maximizes returns while reducing risk.

Active Portfolio Management

Through our partnership with Tivity Labs, we provide hands-on operational support to help our portfolio companies optimize costs, accelerate buildouts, streamline compliance, and expand market share. This level of involvement ensures that our investments are positioned for long-term success in an industry that is constantly evolving.

Why We Invest in Cannabis

Cannabis is one of the fastest-growing industries, with projected market revenues exceeding $50 billion by 2028. By focusing on limited-license states with high wholesale prices and strong regulatory protections, NovaTerra Capital strategically invests in early-mover advantages while supporting long-term business sustainability.